Antengene recently announced the approval of XPOVIO® in Macau for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML). According to a new report published by Allied Market Research, the swarm intelligence market is expected to reach $725.4 million by 2032, growing at a CAGR of 38.6% from 2023 to 2032. Swarm intelligence is used in robotics, AI, optimization, logistics, agriculture, healthcare, and other industries. Swarm intelligence is used in the robotics sector to create collaborative, self-organizing, and emergent behavior-capable robotic systems. Applications for swarm intelligence in the healthcare sector are advantageous, such as examining patient data to enhance disease diagnosis and treatment strategies.
